Mutation in Ribosomal Protein S5 Leads to Spectinomycin Resistance in Neisseria Gonorrhoeae.
Mutation in ribosomal protein S5 leads to spectinomycin resistance in Neisseria gonorrhoeae.
Front Microbiol. 2013; 4: 186
Ilina EN, Malakhova MV, Bodoev IN, Oparina NY, Filimonova AV, Govorun VM
Spectinomycin remains a useful reserve option for therapy of gonorrhea.… Continue reading
MOR Is Not Enough: Identification of Novel Mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens.
MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens.
PLoS One. 2013; 8(6): e67608
Petko J, Justice-Bitner S, Jin J, Wong V, Kittanakom S, Ferraro TN, Stagljar I, Levenson… Continue reading
Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated With Chemotherapy: A Meta-Analysis.
Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis.
PLoS One. 2013; 8(6): e66721
Chen XL, Lei YH, Liu CF, Yang QF, Zuo PY, Liu CY, Chen CZ, Liu YW
Concerns have arisen… Continue reading
Parthenolide Enhances Dacarbazine Activity Against Melanoma Cells.
Parthenolide enhances dacarbazine activity against melanoma cells.
Anticancer Drugs. 2013 Jun 21;
Koprowska K, Hartman ML, Sztiller-Sikorska M, Czyz ME
Dacarbazine induces a clinical response only in 15% of melanoma patients. New treatment strategies may involve combinations of drugs… Continue reading
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.
Eur J Integr Med. 2013 Apr 1; 5(2): 126-140
Bell IR, Schwartz GE, Boyer NN, Koithan M, Brooks AJ
Infectious diseases present public health challenges worldwide. An… Continue reading
Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy.
Evaluating baculovirus as a vector for human prostate cancer gene therapy.
PLoS One. 2013; 8(6): e65557
Swift SL, Rivera GC, Dussupt V, Leadley RM, Hudson LC, Ma de Ridder C, Kraaij R, Burns JE, Maitland NJ, Georgopoulos LJ
Gene… Continue reading